Fig. 1From: COVID-19 monoclonal antibody treatment impact on symptoms and post-COVID conditions among high-risk patients at a Federally Qualified Health CenterPrevalence of symptoms at baseline survey (N = 411). Data on the presence of the following symptoms were also collected, but no patients reported having them at baseline: thromboembolism, chronic kidney disease, need for oxygen, loss of hearing, and depressionBack to article page